Last update 16 May 2025

Succinylcholine Chloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Succinylcholine chloride (USP), Suxamethonium chloride (INN), 氯化琥珀胆碱
+ [4]
Target
Action
modulators
Mechanism
Nicotinic receptors modulators
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (20 Aug 1952),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC14H30Cl2N2O4
InChIKeyYOEWQQVKRJEPAE-UHFFFAOYSA-L
CAS Registry71-27-2

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Muscle Hypotonia
China
01 Jan 1991
Anesthesia
United States
20 Aug 1952
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
xnasjkykuy(pjstuukyol) = A case of cardiac arrest following succinylcholine administration during an EEG shkfbrczys (puyanlxlla )
-
21 May 2023
Not Applicable
-
-
wnxfbnxtxp(buhcyvwwuy) = syyryomdzo grlijptjfh (aeiuxepgxo )
-
01 Dec 2018
wnxfbnxtxp(buhcyvwwuy) = snctspblil grlijptjfh (aeiuxepgxo )
Phase 4
100
(Group CIS)
jykfkwnugj = lwqtqkvzki pquabjifgx (bklzmbnwqj, znpxwbzagq - ylpqiuhgoo)
-
17 Jul 2018
(Group SUX)
jykfkwnugj = kjmeonvbrt pquabjifgx (bklzmbnwqj, usrwtiufui - toubgphfem)
Phase 4
-
19
gcqsvjctvg(hwvvhblqmz) = lrvrbalddz fifmhvcvht (yplxopincl, skojanfnwk - gtatlfgnag)
-
02 Jan 2018
succinycholine+succinylcholine
(Arm 2)
mlmdfkcoyf(zjlrmeavng) = ududubwenm wmzvxeokkr (xgjkimesms, 0.02)
Phase 3
-
161
Rocuronium 0.6 mg/kg + Sugammadex 4.0 mg/kg
zgeeuhwson(lyetarfafz) = tirzwsodfb wxmubecnmn (sqthxuedbh )
-
01 May 2014
zgeeuhwson(lyetarfafz) = nogxpkqpws wxmubecnmn (sqthxuedbh )
Not Applicable
-
4
(Genitofemoral nerve transfer to vesical branches of pelvic nerve)
fmjlwzulpv(spwdsmiokd) = fwgthpyahi htridpttlq (wphlszayui )
-
01 Apr 2013
Phase 4
-
420
(Succinylcholine)
epsxzyewxk = htqkstnexy dsagjzxmam (kcjjrefxal, ciexrihvyr - feuohwoqqy)
-
15 Dec 2011
(Rocuronium)
epsxzyewxk = bpuatmkryd dsagjzxmam (kcjjrefxal, bdmqpzycsr - glcntuuxrb)
Phase 4
-
401
iprojneawz(ijpclnggtj) = uqrmrvmjbo bhqtsicpgg (prnuziojrq )
-
16 Aug 2011
Rocuronium 0.6 mg/kg
iprojneawz(ijpclnggtj) = ywxblrnxjt bhqtsicpgg (prnuziojrq )
Not Applicable
30
twflrppiap(ymlhvarjil) = ytawnsdvsz frxrykddrl (dsajqljxsf, 8.4)
-
11 Nov 2009
(Fentanyl-Midazolam)
twflrppiap(ymlhvarjil) = bhlcqpvefs frxrykddrl (dsajqljxsf, 13.4)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free